A Study of Danoprevir/Ritonavir and Copegus With RO5024048 and/or Pegasys in Patients With Chronic Hepatitis C

NCT01331850 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

381

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C, Chronic

Interventions

DRUG: Copegus
DRUG: Copegus
DRUG: Pegasys
DRUG: Pegasys
DRUG: RO5024048
DRUG: danoprevir
DRUG: ritonavir

Sponsor

Hoffmann-La Roche